← Leaderboards
Xiaoyang Xu
Brigham And Women'S Hospital
$151,132
Attributed
$151,132
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $53.9K · FY2012–14$100K$75K$50K$25K$0
'12
'13
'14
Funding mix
By agency
NIH$151,132 · 1
By mechanism
F32$151,132 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Reza Abdi$32,829,278
- Vivek Kasinath$3,310,857
- Sebastian G. Schneeweiss$14,258,306
- Omid C Farokhzad$3,124,108
- Scott A Oakes$8,379,740
Others in their field
Top investigators on “Alkyl Group”
- Norman Wolmark · Nsabp Foundation, Inc.$52,338,276
- John A Tainer · Scripps Research Institute$15,488,709
- John F Hartwig · University Of California Berkeley$9,923,243
- Susan L Schantz · University Of Illinois Urbana-Champaign$8,855,779
- Tracey J. Woodruff · University Of California, San Francisco$8,855,779
- Peter Leif Bergsagel · Weill Medical College Of Cornell Univ$8,767,247
Research focus
Alkyl GroupAntineoplastic AgentsBaseBiocompatibleBiodistributionBlood CirculationBreast Cancer CellBreast Cancer TreatmentBypassCancer BiologyCancer CellCancer PatientCancer TherapyCatalytic DomainCell InjuryCellsCharacteristicsChemotherapeutic AgentChemotherapyCisplatinClinically RelevantCombined Modality TherapyControlled ReleaseAccomplished Suicide
Grant awards (3)
Sensitize Chemoresistant Breast Cancer by Nano-delivery of siRNA and Cisplatin$45,000
F32 · FY2014 · CA · contact PI
Sensitize Chemoresistant Breast Cancer by Nano-delivery of siRNA and Cisplatin$53,942
F32 · FY2013 · CA · contact PI
Sensitize Chemoresistant Breast Cancer by Nano-delivery of siRNA and Cisplatin$52,190
F32 · FY2012 · CA · contact PI